Picture of SymBio Pharmaceuticals logo

4582 — SymBio Pharmaceuticals News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: SymBio Pharmaceuticals - 6-MTH parent results

Aug 4 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Dec 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             3.15                1.36             9.15     
                (+131.3 pct)         (-32.1 pct)     (+206.4 pct) 
  Operating     loss 194 mln          loss 1.84          1.36     
  Recurring     loss 203 mln          loss 1.88          1.35     
  Net           loss 205 mln          loss 1.88          1.15     
  EPS           loss 5.37 yen      loss 62.47 yen      29.99 yen  
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T

Recent news on SymBio Pharmaceuticals

See all news